http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003055215-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
filingDate 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d82d053a35cfb3e90f45e8df123954b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a72eeb27d2d5dc2975210b5331d9eeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d2a5d1979a603baf694b9b45aa8ddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_053a94f4767d43444e5135fd6a31b343
publicationDate 2003-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003055215-A
titleOfInvention Liver fibrosis inhibitor
abstract (57) [Abstract] [Problem] To develop a component which has a remarkable inhibitory effect on liver fibrosis, Using this as an active ingredient, it provides a liver fibrosis inhibitor which can be applied not only to drugs such as drugs for liver diseases, but also health foods for improving and maintaining liver function, and foods and drinks such as foods for patients. . A hepatic fibrosis inhibitor containing cysteine (which may be in the form of a salt), comprising only cysteine as an active ingredient for inhibiting hepatic fibrosis; When the daily dose or intake is expressed in terms of free substance and oral administration or oral intake, at least 200 mg of liver fibrosis inhibitor. It can be carried out in the form of a medicine, food or drink. It is useful for liver diseases, especially cirrhosis such as compensated cirrhosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011013791-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9029385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9474733-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009052630-A1
priorityDate 2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5862
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6035
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559262
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491824
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6124

Total number of triples: 42.